The risk of placental abruption when using prostaglandins for cervical ripening in women with preeclampsia: Comparing misoprostol versus dinoprostone

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 23, Issue 9, 2010, Pages 988-993

  De Tejada, Begoña Martinez ^a   Martillotti, Gabriella ^a   Lapaire, Olav ^b   Hoesli, Irene ^b   Irion, Olivier ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

cervical ripening; Placental abruption; preeclampsia; prostaglandins

Indexed keywords

ANTIHYPERTENSIVE AGENT; MAGNESIUM SULFATE; MISOPROSTOL; OXYTOCIN; PROSTAGLANDIN E2;

ADOLESCENT; ADULT; AMNIOTOMY; ARTICLE; CESAREAN SECTION; CONTINUOUS INFUSION; CONTROLLED STUDY; DRUG SAFETY; EPILEPSY; FEMALE; FETUS HEART RATE; FETUS MONITORING; HUMAN; INCIDENCE; LABOR INDUCTION; MAJOR CLINICAL STUDY; NULLIPARA; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; POST HOC ANALYSIS; PREECLAMPSIA; PREGNANCY; PRIORITY JOURNAL; RISK ASSESSMENT; SOLUTIO PLACENTAE; SUPPOSITORY; SWITZERLAND; TWIN PREGNANCY; UNIVERSITY HOSPITAL; UTERINE CERVIX RIPENING; VAGINA PESSARY; VAGINAL DELIVERY;

ABRUPTIO PLACENTAE; ADMINISTRATION, INTRAVAGINAL; ADOLESCENT; ADULT; CERVICAL RIPENING; DINOPROSTONE; FEMALE; HUMANS; INCIDENCE; LABOR, INDUCED; MIDDLE AGED; MISOPROSTOL; OXYTOCICS; PRE-ECLAMPSIA; PREGNANCY; PROSTAGLANDINS; RISK; YOUNG ADULT;

EID: 77955904382     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767050903443475     Document Type: Article

References (20)

1. Report of the National High Blood Pressure Education Program Working Group on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 2000;183:S1-S22.
2. Sibai BM. Chronic hypertension in pregnancy. Obstet Gynecol 2002;100:369-377.
3. Duley L. Pre-eclampsia and the hypertensive disorders of pregnancy. Br Med Bull 2003;67:161-176.
4. Sibai BM. Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181-192.
5. Hnat MD, Sibai BM, Caritis S, Hauth J, Lindheimer MD, MacPherson C, et al. Perinatal outcome in women with recurrent preeclampsia compared with women who develop preeclampsia as nulliparas. Am J Obstet Gynecol 2002;186:422-426.
6. Buchbinder A, Sibai BM, Caritis S, Macpherson C, Hauth J, Lindheimer MD, et al. Adverse perinatal outcomes are significantly higher in severe gestational hypertension than in mild preeclampsia. Am J Obstet Gynecol 2002;186:66-71.
7. van Pampus MG, Dekker GA, Wolf H, Huijgens PC, Koopman MM, von Blomberg BM, et al. High prevalence of hemostatic abnormalities in women with a history of severe preeclampsia. Am J Obstet Gynecol 1999;180:1146-1150. (Pubitemid 29259008)
8. AlfirevicZ,Roberts D,Martlew V.Howstrong is the association between maternal thrombophilia and adverse pregnancy outcome? A systematic review. Eur J Obstet Gynecol Reprod Biol 2002;101:6-14.
9. Sibai BM. Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count. Obstet Gynecol 2004;103:981-991.
10. Macer J, Buchanan D, Yonekura ML. Induction of labor with prostaglandin E2 vaginal suppositories. Obstet Gynecol 1984;63:664-668. (Pubitemid 14143920)
11. ACOGCommittee Opinion.Number 283,May 2003.NewUS. Food and Drug Administration labeling on Cytotec (misoprostol) use and pregnancy. Obstet Gynecol 2003;101:1049-1050.
12. Lapaire O, Zanetti-Dallenbach R, Weber P, Hosli I, Holzgreve W, Surbek D. Labor induction in preeclampsia: is misoprostol more effective than dinoprostone? J Perinat Med 2007;35:195-199.
13. FontenotTM,LewisDF,Brent BarzonC, JonesEM,Moore JA, Evans AT. Abruptio placenta associated withmisoprostol use in women with preeclampsia. J Reprod Med 2005;50:653-658.
14. Oyelese Y, Ananth CV. Placental abruption. Obstet Gynecol 2006;108:1005-1016.
15. Royal College of Obstetricians and Gynaecologists. The use of electronic fetal monitoring.The use of cardiotocography in intrapartum fetal surveillance. In: Evidence-Based Clinical Guideline, Number 8: Clinical Effectiveness Support Unit. London: RCOG Press, 2001, Available at: http://www.rcog. org.uk/files/rcog-corp/uploaded-files/NEBEFMGuidelinFinal 2may2001.pdf
16. Sibai BM, Gordon T, Thom E, Caritis SN, Klebanoff M, McNellis D, Paul RH. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units. Am J Obstet Gynecol 1995;172:642-648.
17. Nahar S, Rasul CH, Sayed A, Azim AK. Utility of misoprostol for labor induction in severe pre-eclampsia and eclampsia. J Obstet Gynaecol Res 2004;30:349-353.
18. Sahin HG, Sahin HA, Surucu R, Guvercinci M. A study of intravaginal misoprostol for induction of labor in toxemia of pregnancy. Int J Gynaecol Obstet 2001;75:3-9.
19. Wing DA. Labor induction with misoprostol. Am J Obstet Gynecol 1999;181:339-345.
20. Surbek D, Heinzl S, Holzgreve W, Deydoux J, Pletscher W. L'off-label use de médicaments en gynécologie et obstétrique [Off-label prescription in obstetrics and gynaecology] [In French]. Avis d'experts de la Société suisse de gynécologie et obstétrique 2007;23.